**Core Concept**
Visceral leishmaniasis, also known as kala-azar, is a severe form of leishmaniasis that affects the internal organs, particularly the spleen, liver, and bone marrow. The treatment of visceral leishmaniasis involves the use of antimonial compounds, antifungals, and other medications to target the parasite and alleviate symptoms.

**Why the Correct Answer is Right**
The treatment of visceral leishmaniasis typically involves the use of antimonial compounds such as sodium stibogluconate or meglumine antimoniate, which act by inhibiting the parasite's enzyme glycolytic pathway and ultimately leading to the death of the parasite. Other medications used in the treatment of visceral leishmaniasis include antifungals like amphotericin B, miltefosine, and paromomycin.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because it is not a commonly used medication in the treatment of visceral leishmaniasis.
* **Option B:** This option is incorrect because it is typically used in the treatment of other conditions such as malaria or babesiosis, not visceral leishmaniasis.
* **Option C:** This option is incorrect because it is not a standard medication used in the treatment of visceral leishmaniasis.

**Clinical Pearl / High-Yield Fact**
It is essential to note that the treatment of visceral leishmaniasis requires a combination of medications, and resistance to antimonial compounds has been reported in some regions. Regular monitoring of the patient's response to treatment and the use of alternative medications are crucial in managing this condition.

**Correct Answer: A. This option is incorrect because it is not a commonly used medication in the treatment of visceral leishmaniasis.**